Sales revenues for March 2024

“Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for March 2024 the Company recorded a decrease in sales of 24% compared to the same month of the previous year, incl. 8% decrease in domestic sales and 32% decrease in export sales, mainly due to destabilizing market dynamics on the main export destinations.

From the beginning of 2024, the Company recorded a decrease in sales of 11%, incl. 1% decrease of domestic sales and 16% decrease in export sales.